INTERNATIONAL PATENT: AC IMMUNE SA FILES APPLICATION FOR "ANTIBODY DRUG CONJUGATES TARGETING PROTEINOPATHIES AND USES THEREOF"

GENEVA, July 2 -- AC IMMUNE SA (EPFL Innovation ParkBuilding BCH-1015 Lausanne) filed a patent application (PCT/IB2024/063062) for "ANTIBODY DRUG CONJUGATES TARGETING PROTEINOPATHIES, AND USES THEREOF" on Dec 20, 2024. With publication no. WO/2025/134068, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NAMPALLY, Sreenivasachary (EPFL Innovation ParkBuilding BCH-1015 Lausanne), MARTIN, Camille (EPFL Innovation ParkBuilding BCH-1015 Lausanne), KOSCO-VILBOIS, Marie (EPFL Innovation ParkBuilding BCH-1015 Lausanne), ADOLFSSON,...